A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Good long-term results of sacral neuromodulation for endometriosis related chronic pelvic pain
Tekijät: Zegrea, Adrian; Ojala, Emilia; Kirss, Jaan; Suvitie, Pia; Varpe, Pirita; Makela-Kaikkonen, Johanna; Rautio, Tero; Seikkula, Jaana; Ukkonen, Mika; Lavonius, Maija; Pinta, Tarja
Kustantaja: Springer Science and Business Media LLC
Kustannuspaikka: LONDON
Julkaisuvuosi: 2025
Journal: BMC Women's Health
Tietokannassa oleva lehden nimi: BMC Women's Health
Lehden akronyymi: BMC WOMENS HEALTH
Artikkelin numero: 162
Vuosikerta: 25
Numero: 1
Sivujen määrä: 6
eISSN: 1472-6874
DOI: https://doi.org/10.1186/s12905-025-03699-y
Verkko-osoite: https://doi.org/10.1186/s12905-025-03699-y
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/491891199
Background: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good results in patients with chronic pelvic pain (CPP). Our aim was to analyze long-term results of SNM in Finnish patients with endometriosis related CPP.
Methods: This is a register-based retrospective study including all the endometriosis patients treated with SNM for CPP in Finland between 2004 and 2017. There were four centers where these procedures were performed, two University Hospitals and two Central Hospitals. Long-term results were assessed by phone interview in spring 2021.
Results: A total of 16 women with endometriosis, with a median age of 39 (25-50) years, underwent SNM treatment for chronic pelvic pain (CPP), with the median follow-up time of 73 (48-85) months. The Implantable Pulse Generator (IPG) was implanted to 14 patients (88%). By the end of the follow-up period, 10 patients (62,5% of all patients and 71% of those who received IPG) had a functional SNM. Pain was assessed by numeral rating scale (NRS) and decreased from a median of 7.4 (3.6-10) to 2.3 (0-6.5).
Conclusions: SNM could be a good option in the treatment of endometriosis related chronic pelvic pain when standard therapy is not enough.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This study was conducted without external funding.